VRCA Investors Have Opportunity to Lead Verrica Pharmaceuticals Inc. Securities Fraud Lawsuit

LOS ANGELES, June 16, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA). Class...

Click to view original post